ecrin-mdr-crcClinical2008Colorectal cancer metastaticMETASTATIC COLORECTAL CANCER PATIENTSMetastatic Colorectal Cancer PatientsColorectal Cancer MetastaticInterventionalhttps://newmdr.ecrin.org/Study/2542918Italy1CAMPTOAVASTINOxaliplatinFluorouracilECRIN MDROngoingfalseAN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III STUDY OF SECOND-LINE CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS WHO HAVE RECEIVED FIRST-LINE CHEMOTHERAPY PLUS BEVACIZUMABPrimary objectives: To compare the progression-free-survival of second-line chemotherapy with Bevacizumab to second-line chemotherapy alone in patients treated with first-line chemotherapy + Bevacizumab. Primary endpoints: progression-free-survival2008-01-1525429182007-002886-11